 | Up a level |
Rosker, Christian; Salvarani, Nicolò; Rohr, Stephan (November 2010). Resveratrol reduces myofibroblast arrhythmogenicity. BMC Pharmacology, 10(Suppl), A3. BioMed Central 10.1186/1471-2210-10-S1-A3
Salvarani, Nicolò; Maguy, Ange; De Simone, Stefano Andrea; Miragoli, Michele; Jousset, Florian; Rohr, Stephan (2017). TGF-β 1 (Transforming Growth Factor-β 1 ) Plays a Pivotal Role in Cardiac Myofibroblast Arrhythmogenicity. Circulation - arrhythmia and electrophysiology, 10(5), e004567. Lippincott Williams & Wilkins 10.1161/CIRCEP.116.004567
Grand, Teddy; Salvarani, Nicolò; Jousset, Florian; Rohr, Stephan (2014). Aggravation of cardiac myofibroblast arrhythmogeneicity by mechanical stress. Cardiovascular research, 104(3), pp. 489-500. Oxford University Press 10.1093/cvr/cvu227
Rosker, Christian; Salvarani, Nicolò; Schmutz, Stephan; Grand, Teddy; Rohr, Stephan (2011). Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of α-smooth muscle actin containing stress fibers. Circulation research, 109(10), pp. 1120-1131. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/CIRCRESAHA.111.244798
Rosker, Christian; Salvarani, Nicolò; Rohr, Stephan (2009). Reducing Myofibroblast Arrhythmogeneicity by Pharmacological Targeting of Their Cytoskeleton. Circulation, 120, S635; abstract 2424. Lippincott Williams & Wilkins
Rosker, Christian; Salvarani, Nicolò; Rohr, Stephan (2009). Modification of Actin Fibers Changes the Electrical Phenotype of Cardiac Myofibroblasts. BMC pharmacology, 9(Supple), A15. London: BioMed Central 10.1186/1471-2210-9-S2-A15
